100 related articles for article (PubMed ID: 25416211)
1. [Expression of epidermal growth factor receptor and concentrations of epidermal growth factor and melatonin in endometrial carcinoma].
Dznelashvili N; Kasradze D; Tavartkiladze A
Georgian Med News; 2014 Oct; (235):17-24. PubMed ID: 25416211
[TBL] [Abstract][Full Text] [Related]
2. [Epidermal growth factor receptor expression and epidermal growth factor blood plasma content in simple and complex endometrial hyperplasia].
Dznelashvili N; Kasradze D; Tavartkiladze A; Mariamidze A
Georgian Med News; 2014 Jan; (226):59-65. PubMed ID: 24523335
[TBL] [Abstract][Full Text] [Related]
3. [Expression of epidermal growth factor receptor and plasmatic level of melatonin in simple and complex endometrial hyperplasia].
Dznelashvili NO; Kasradze DG; Tavartkiladze AG; Mariamidze AG; Dzhinchveladze DN
Georgian Med News; 2013 Oct; (223):91-5. PubMed ID: 24214601
[TBL] [Abstract][Full Text] [Related]
4. [Concentration of epidermal growth factor (EGF) in serum of women with endometrial cancer].
Tomaszewski J; Miturski R; Kotarski J
Ginekol Pol; 1996 May; 67(5):248-53. PubMed ID: 8925996
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptor immunostaining and epidermal growth factor receptor-tyrosine kinase activity in proliferative and neoplastic human endometrium.
Miturski R; Semczuk A; Postawski K; Jakowicki JA
Tumour Biol; 2000; 21(6):358-66. PubMed ID: 11006576
[TBL] [Abstract][Full Text] [Related]
6. Effect of the molecular targeted drug, erlotinib, against endometrial cancer expressing high levels of epidermal growth factor receptor.
Nishimura T; Nakamura K; Yamashita S; Ikeda S; Kigure K; Minegishi T
BMC Cancer; 2015 Dec; 15():957. PubMed ID: 26673416
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical study of estradiol, epidermal growth factor, transforming growth factor alpha and epidermal growth factor receptor in endometrial neoplasia.
Yokoyama Y; Takahashi Y; Hashimoto M; Morishita S; Tamaya T
Jpn J Clin Oncol; 1996 Dec; 26(6):411-6. PubMed ID: 9001345
[TBL] [Abstract][Full Text] [Related]
8. [Epidermal growth factor receptors and their ligands in endometrial carcinoma: correlation with clinico-morphologic factors and steroid receptors].
Gershtein ES; Bocharova LB; Ermilova VD; Laktionov KP; Kushlinskiĭ
Vopr Onkol; 2000; 46(2):180-6. PubMed ID: 10853417
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of epidermal growth factor, transforming growth factor, and c-erbB2 in ovarian cancer.
Balcan E; Demirkiran F; Aydin Y; Sanioglu C; Bese T; Arvas M; Akçay T; Cift T
Int J Gynecol Cancer; 2012 Sep; 22(7):1138-42. PubMed ID: 22914212
[TBL] [Abstract][Full Text] [Related]
10. FGF2 transcript levels are positively correlated with EGF and IGF-1 in the malignant endometrium.
Soufla G; Sifakis S; Spandidos DA
Cancer Lett; 2008 Feb; 259(2):146-55. PubMed ID: 18006148
[TBL] [Abstract][Full Text] [Related]
11. Expression of the epidermal growth factor system in endometrioid endometrial cancer.
Ejskjaer K; Sørensen BS; Poulsen SS; Forman A; Nexø E; Mogensen O
Gynecol Oncol; 2007 Jan; 104(1):158-67. PubMed ID: 16962163
[TBL] [Abstract][Full Text] [Related]
12. [Role of epidermal growth factor signaling system in the pathogenesis of endometriosis under estrogen deprivation conditions].
Wang YQ; Yin LR; Guo RM; Sheng W
Zhonghua Fu Chan Ke Za Zhi; 2013 Jun; 48(6):447-52. PubMed ID: 24103125
[TBL] [Abstract][Full Text] [Related]
13. [Significance of expression of epidermal growth factor (EGF) and its receptor (EGFR) in chronic cholecystitis and gallbladder carcinoma].
Zhou YM; Li YM; Cao N; Feng Y; Zeng F
Ai Zheng; 2003 Mar; 22(3):262-5. PubMed ID: 12654182
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor expression and endometrial cancer histotypes.
Jasonni VM; Santini D; Amadori A; Ceccarelli C; Naldi S
Ann N Y Acad Sci; 1994 Sep; 734():298-305. PubMed ID: 7978930
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of the sensitivity of endometrial cancer cells to epidermal growth factor and steroid hormones.
Gershtein ES; Shatskaya VA; Kostyleva OI; Ermilova VD; Kushlinsky NE; Krasil'nikov MA
Cancer; 1995 Dec; 76(12):2524-9. PubMed ID: 8625080
[TBL] [Abstract][Full Text] [Related]
16. Serum sErbB1 and epidermal growth factor levels as tumor biomarkers in women with stage III or IV epithelial ovarian cancer.
Baron AT; Lafky JM; Boardman CH; Balasubramaniam S; Suman VJ; Podratz KC; Maihle NJ
Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):129-37. PubMed ID: 10067810
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor in human breast cancer, endometrial carcinoma and lung cancer. Its relationship to epidermal growth factor receptor, estradiol receptor and tumor TNM.
Bolufer P; Lluch A; Molina R; Alberola V; Vazquez C; Padilla J; Garcia-Conde J; Llopis F; Guillem V
Clin Chim Acta; 1993 Apr; 215(1):51-61. PubMed ID: 8513568
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis and apoptosis-related factors Bcl-2, Bax, tumor necrosis factor-alpha, and NF-kappaB in human endometrial hyperplasia and carcinoma.
Vaskivuo TE; Stenbäck F; Tapanainen JS
Cancer; 2002 Oct; 95(7):1463-71. PubMed ID: 12237915
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic Ras modulates epidermal growth factor responsiveness in endometrial carcinomas.
Kato K; Ueoka Y; Kato K; Tamura T; Nishida J; Wake N
Eur J Cancer; 1998 Apr; 34(5):737-44. PubMed ID: 9713283
[TBL] [Abstract][Full Text] [Related]
20. Expression of the retinoblastoma-related gene Rb2/p130 is downregulated in atypical endometrial hyperplasia and adenocarcinoma.
Susini T; Massi D; Paglierani M; Masciullo V; Scambia G; Giordano A; Amunni G; Massi G; Taddei GL
Hum Pathol; 2001 Apr; 32(4):360-7. PubMed ID: 11331952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
